Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-07-16
2009-02-24
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S124000, C546S125000
Reexamination Certificate
active
07495010
ABSTRACT:
Muscarinic Acetylcholine Receptor Antagonists and methods of using them are provided.
REFERENCES:
patent: 2800478 (1957-07-01), Zirkle et al.
patent: 2800481 (1957-07-01), Zirkle et al.
patent: 3634852 (1972-01-01), Hartley et al.
patent: 5590645 (1997-01-01), Davies et al.
patent: 5780466 (1998-07-01), Emonds-Alt et al.
patent: 5860419 (1999-01-01), Davies et al.
patent: 5873360 (1999-02-01), Davies et al.
patent: 6248752 (2001-06-01), Smith
patent: 6262066 (2001-07-01), Tulshian et al.
patent: 6350758 (2002-02-01), Kozikowski et al.
patent: 6455527 (2002-09-01), Tulshian et al.
patent: 6750226 (2004-06-01), Forner et al.
patent: 7232841 (2007-06-01), Busch-Petersen et al.
patent: 7276521 (2007-10-01), Busch-Petersen et al.
patent: 2005/0020660 (2005-01-01), Guyaux et al.
patent: 2005/0113417 (2005-05-01), Mammen et al.
patent: 2005/0209272 (2005-09-01), Fernandez et al.
patent: 2005/0277676 (2005-12-01), Laine et al.
patent: 2006/0160844 (2006-07-01), Belmonte et al.
patent: 2006/0178395 (2006-08-01), Belmonte et al.
patent: 2007/0129396 (2007-06-01), Wan et al.
patent: 2007/0135478 (2007-06-01), Palovich et al.
patent: 2007/0149598 (2007-06-01), Busch-Petersen et al.
patent: 2007/0173646 (2007-07-01), Laine et al.
patent: 2007/0179180 (2007-08-01), Busch-Petersen et al.
patent: 2007/0179184 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185088 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185090 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185148 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185155 (2007-08-01), Laine et al.
patent: 2007/0232599 (2007-10-01), Palovich et al.
patent: 2007/0249664 (2007-10-01), Laine et al.
patent: 0069715 (1982-06-01), None
patent: 2064336 (1981-06-01), None
patent: 2129691 (1984-05-01), None
patent: 2169265 (1986-07-01), None
patent: 2178965 (1987-02-01), None
patent: 2242134 (1991-09-01), None
patent: 87/05213 (1987-09-01), None
patent: 2004/012684 (2004-02-01), None
patent: 2006/050239 (2006-05-01), None
patent: 2006/055503 (2006-05-01), None
patent: 2006/055553 (2006-05-01), None
patent: 2006/062883 (2006-06-01), None
patent: 2006/062931 (2006-06-01), None
patent: 2006/065755 (2006-06-01), None
patent: 2006/065788 (2006-06-01), None
patent: 2007/016639 (2007-02-01), None
patent: 2007/016650 (2007-02-01), None
patent: 2007/018508 (2007-02-01), None
patent: 2007/018514 (2007-02-01), None
patent: 2007/022351 (2007-05-01), None
Brown,History and Basic Properties, Humana Press, USA pp. 7-9 (1989).
Costello, et al.,American Journal of Physiology, vol. 276 (5) pp. L709-L714 (1999).
Hedge, et al.,Life Sciences, vol. 64 (6/7) pp. 419-428 (1999).
Ikeda, et al.,Naunyn-Schmiedeberg's Arch Pharmacol., vol. 366, pp. 97-103, (2002).
Minette, et al.,Journal of Applied Physiology, vol. 67(6) pp. 2461-2465 (1989).
Oprins, et al.,Annals of the New York Academy of Sciences, vol. 915 pp. 102-106 (2000).
Ran, et al.,Yaoxue Xuebao, vol. 19 (5) pp. 361-366 (1984) Abstract only.
Sarau,Mol. Pharmacol., vol. 56 (3) p. 657-63 (1999).
Van Rossum, et al.,Arch. Int. Pharmacodyn., vol. 143 p. 299 (1963).
Wu, et al.,Zhongguo Yaowu Huazue Zazhi, vol. 3 (1) pp. 23-26 (1993)Abstract only.
Zirkle, et al.,J Med Chem, vol. 27 pp. 1269-1279 (1962).
Zirkle, et al.,J Med Chem, vol. 27 pp. 1279-1285 (1962).
Zirkle, et al.,J Med Chem, vol. 5 pp. 341-356 (1962).
Zhang, et al.,J Med Chem, vol. 44 pp. 3937-3945 (2001).
U.S. Appl. No. 10/585,830, filed Jul. 12, 2006, Laine, et al.
U.S. Appl. No. 10/598,743, filed Sep. 11, 2006, Budzik, et al.
U.S. Appl. No. 10/598,750, filed Sep. 11, 2006, Jin, et al.
U.S. Appl. No. 10/599,717, filed Oct. 6, 2006, Laine, et al.
U.S. Appl. No. 11/570,981, filed Dec. 20, 2006, Cooper, et al.
U.S. Appl. No. 11/573,097, filed Feb. 2, 2007, Busch-Petersen, et al.
U.S. Appl. No. 11/573,099, filed Feb. 2, 2007, Busch-Petersen, et al.
U.S. Appl. No. 11/766,318, filed Jun. 21, 2007, Busch-Petersen, et al.
U.S. Appl. No. 11/766,371, filed Jun. 21, 2007, Busch-Petersen, et al.
U.S. Appl. No. 11/774,885, filed May 1, 2006, Wan, et al.
Database CAOLD on STN, No. CA 58:4510b. 3-substituted tropane derivatives-(III) 3-substituted tropane carbinol, alkenes, and alkanes, Abstract Zirkle et al., vol. 58 1963.
Ran, et al.,Yaoxue Xuebao, vol. 19 (5) pp. 361-366 (1984), with translation.
Wu, et al.,Zhongguo Yaowu Huaxue Zazhi, vol. 3(1) pp. 23-26 (1993), with translation.
Yu, et al.,Yaoxue Xuebao, vol. 18(10) pp. 766-774 (1983), with translation.
Zhang, et al.,Yaoxue Xuebao, vol. 20(10) pp. 752-758 (1985), with translation.
Belmonte Kristen E.
Busch-Petersen Jakob
Laine Dramane I.
Palovich Michael R.
Dentz Bernard
Dinner Dara L.
Furman Theodore R.
Gallis David E
Glaxo Group Limited
LandOfFree
Muscarinic acetylcholine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarinic acetylcholine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic acetylcholine receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4066787